InvestorsHub Logo
Followers 17
Posts 3258
Boards Moderated 0
Alias Born 12/03/2009

Re: None

Tuesday, 03/12/2019 12:59:56 PM

Tuesday, March 12, 2019 12:59:56 PM

Post# of 440
$BTCY's accomplishments and upcoming milestones:
•Bioflux was named Best Remote Patient Monitoring Solution by MedTech Breakthrough on June 6, 2018
•Direct sales representatives are positioned in six states across the country with plans to expand the current sales force.
•Reimbursement by private payers and MEDICARE for the Bioflux solution is progressing successfully without any reported issues.
•The company will continue to build out infrastructure and operations to support expansion and growth.
•Prepare for FDA filing of Biopatch, an ECG patch which offers an alternative to the 3-lead system for patients with less complicated cardiac conditions, in early 2019 to garner incremental revenue and expand the company’s product portfolio.

“We appreciate the commitment of our existing shareholders and we will continue to be prudent in executing future transactions that maximize shareholder value and minimize risk,” said Mr. Al-Siddiq. “We believe Biotricity has a great opportunity as we expand our commercial footprint and continue to innovate for physicians and patients alike. I look forward to providing updates in the near-term on our latest initiatives.”

https://www.otcmarkets.com/stock/BTCY/news/Biotricity-Provides-End-of-Year-Shareholder-Update?id=215254

All posts are speculative and my opinion only. NOT investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BTCY News